2122 - The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Krithia Srinivasan, MD/MPH (she/her/hers)

Fellow
Stanford
Palo Alto, California, United States

AS

Amy Spallone, M.D.

University of Texas MD Anderson Cancer Center
Houston, Texas, United States
FK

Fareed Khawaja, MBBS

Assistant Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
JS

Joseph Sassine, MD

Assistant Professor of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Oscar Morado Aramburo, MD

Onco-Transplant ID Fellow
The University of Texas MD Anderson Cancer Center
houston, Texas, United States
Anthony J. Febres-Aldana, MD

Clinical Fellow
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
GR

Gabriella Rondon, MD

The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
JR

Jeremy Ramdial, MD

University of Texas MD Anderson Cancer Center
Houston, Texas, United States
ES

Elizabeth Shpall, MD

The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
EA

Ella Ariza-Heredia, MD

The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Roy F. Chemaly, MD/MPH

Professor
MD Anderson
Houston, Texas, United States